Eastgate Biotech Corp.
ETBI News Today: Stay Updated with the Latest Eastgate Biotech Corp. News in Real Time
Find ETBI news now at Meyka AI. Stay informed with the latest Eastgate Biotech Corp. stocks updates, including price news, market analysis, and expert insights.
Volume spike lifts QPTFF Quest PharmaTech (PNK) $0.03 Apr 04 2026: follow-up
QPTFF stock sees a volume surge to 225,625 shares on Apr 04 2026; short-term momentum and risks outlined
ITRM Iterum Therapeutics plc NASDAQ Q4 2025 results 03 Apr 2026: Earnings drivers and outlook
ITRM stock closed at $0.03 on 03 Apr 2026 after Q4 2025 results. Read Meyka AI earnings spotlight and short-term outlook for ITRM stock
NECA stock at $0.0485 on Apr 03, 2026 PNK: 102.17% model upside signals momentum
NECA stock rises to $0.0485 on Apr 03, 2026; Meyka AI forecasts **102.17%** upside vs USD 0.0485
4564.T OncoTherapy Science JPX +9.09% to JPY 24.00 on 03 Apr 2026: volume surge signals clinical interest
4564.T stock jumps to JPY 24.00 on 03 Apr 2026 with heavy volume; analysis, grade and forecast from Meyka AI
CHM.CN Waverunner Capital Inc. CNQ 03 Apr 2026: C$0.05 after 900% jump, monitor liquidity
CHM.CN stock update: price C$0.05 after 900% jump, market cap CAD 37,211,650.00. Trading, valuation and forecast insights
FWM.CN Flow Metals Corp. (CNQ) jumps 60.00% on 03 Apr 2026: top gainer insight
FWM.CN stock jumps 60.00% to CAD 0.16 on 03 Apr 2026; analysis, grade and a CAD 0.14 quarterly forecast
PHASQ falls 99.00% to $0.000001 on 03 Apr 2026: immediate liquidity risk
PHASQ stock fell 99.00% to $0.000001 on 03 Apr 2026; Meyka AI explains drivers, liquidity, and forecast for investors
Earnings 06 Apr: GeNeuro GNRO.PA EURONEXT pre-market 03 Apr 2026: readout risk
GNRO.PA stock pre-market update ahead of 06 Apr earnings; clinical readout may move price, forecast and Meyka AI grade included
VR.CN Victory Resources Corp (CNQ) Apr 02 2026 C$0.10 +900.00%: monitor volume
VR.CN stock at C$0.10 on Apr 02 2026 with +900.00% intraday move on CNQ; high-volume mover, watch liquidity and risks